Marijuana and the Cannabinoids

Recommendations

Info

Chemistry of Cannabis Constituents 21 Table 1 (continued) (continued) 5. ∆ 8 -THC type: ∆ 8 -THC and its acid precursor are considered as THC and THC acid artifacts, respectively. The 8,9 double-bond position is thermodynamically more stable than the 9,10 position. ∆ 8 -THC is approx 20% less active than THC.
22 Brenneisen Table 1 (continued) (continued) 6. Cannabicyclol (CBL) type: Three cannabinoids characterized by a five-atom ring and C 1 -bridge instead of the typical ring A are known: CBL, its acid precursor, and the C 3 side-chain analog. CBL is known to be a heat-generated artifact from CBC. 7. Cannabielsoin (CBE) type: Among the five CBE-type cannabinoids, which are artifacts formed from CBD, are CBE and its acid precursors A and B.
Page 1 and 2: Marijuana and the Cannabinoids Edit
Page 3 and 4: F O R E N S I C SCIENCE AND MEDICIN
Page 5 and 6: © 2007 Humana Press Inc. 999 River
Page 8 and 9: Contents Preface ..................
Page 10 and 11: Contributors RUDOLF BRENNEISEN, PhD
Page 12 and 13: Cannabis and Natural Cannabis Medic
Page 28 and 29: Chemistry of Cannabis Constituents
Page 62 and 63: Chemical Fingerprinting of Cannabis
Page 78 and 79: Marijuana Smoke Condensate 67 Chapt
Page 80 and 81: Marijuana Smoke Condensate 69 Fig.
Page 82 and 83:
Marijuana Smoke Condensate 71 fied,
Page 84 and 85:
Marijuana Smoke Condensate 73 Table
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Marijuana Smoke Condensate 93 of th
Page 106 and 107:
Marijuana Smoke Condensate 95 12. N
Page 108 and 109:
Pharmacology of Cannabinoids 97 Cha
Page 110 and 111:
Pharmacology of Cannabinoids 99 Fig
Page 112 and 113:
Pharmacology of Cannabinoids 101 an
Page 114 and 115:
Pharmacology of Cannabinoids 103 Fi
Page 116 and 117:
Page 118 and 119:
Pharmacology of Cannabinoids 107 CB
Page 120 and 121:
Pharmacology of Cannabinoids 109 st
Page 122 and 123:
Page 124 and 125:
Pharmacology of Cannabinoids 113 ti
Page 126 and 127:
Page 128 and 129:
Pharmacology of Cannabinoids 117 do
Page 130 and 131:
Pharmacology of Cannabinoids 119 19
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Therapeutic Potential of Cannabinoi
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Immunoassays to Detect Cannabis Abu
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
165 Table 2 Analytical Recovery of
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
MS for Detection of Cannabinoids 17
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
189 Table 1 Published Methods for M
Page 202 and 203:
191 30 THCA SPE No derivatization L
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Human Cannabinoid Pharmacokinetics
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Medical and Health Consequences of
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Effects of Marijuana on Immune Defe
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Page 282 and 283:
Page 284 and 285:
Page 286 and 287:
Page 288 and 289:
Marijuana and Driving Impairment 27
Page 290 and 291:
Page 292 and 293:
Page 294 and 295:
Page 296 and 297:
Page 298 and 299:
Page 300 and 301:
Page 302 and 303:
Page 304 and 305:
Page 306 and 307:
Postmortem Considerations 295 Chapt
Page 308 and 309:
Postmortem Considerations 297 vascu
Page 310 and 311:
Postmortem Considerations 299 where
Page 312 and 313:
Postmortem Considerations 301 18. B
Page 314 and 315:
Cannabinoid Effects on Mental Proce
Page 316 and 317:
Page 318 and 319:
Page 320 and 321:
Page 322 and 323:
Page 324 and 325:
Page 326:
Page 329 and 330:
318 Index THC, 283, 284 THC/11-carb
Page 331 and 332:
320 Index Immune system, cannabinoi
Page 333:
322 Index ∆9-Tetrahydrocannabinol
show all

Marijuana and the Cannabinoids

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?